The Immunomodulation Effect of Blood Transfusion in Operative Spine Surgery Patients
NCT02069210 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2014-02-24
Summary
The purpose of this study is to investigate the effect of transfusion of allogeneic (homologous) red cells on the immunologic parameters such as T-cells as well as natural killer cell count/function, various interleukins, TNF alpha and other immunologic relevant parameters on postoperative day 1,3 and 5-7 in patients undergoing spine surgery.
Conditions
- Infection After Transfusion
Interventions
- OTHER
-
Blood transfusion
Intraoperative blood transfusion
Sponsors & Collaborators
-
Wolf-Schleinzer-Stiftung
collaborator UNKNOWN -
Mahidol University
lead OTHER
Principal Investigators
-
Sirilak Suksompong, MD · Department of Anesthesiology, Faculty of medicine Siriraj Hospital, Mahidol University
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-05-31
- Primary Completion
- 2015-12-31
- Completion
- 2015-12-31
Countries
- Thailand
Study Locations
More Related Trials
-
A Randomized Controlled, Open, Single-center Clinical Study Evaluating the Efficacy and Safety of Umbilical Cord Blood Mononuclear Cells in Patients with Refractory Immune Effector Cell-related Hemocytopenia
NCT06729320 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Identification and Analysis of Immunomodulatory Molecules in Patients With Hematologic Disorders and Healthy Volunteers
NCT00223483 ·Status: COMPLETED
-
Immunomodulation Following Transfusion
NCT00810810 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic Diseases
NCT06294691 ·Status: RECRUITING ·Phase: PHASE3
-
Study on the Impact of Stem Cell Donation and Bone Marrow Harvesting on Unrelated Donors
NCT01884610 ·Status: COMPLETED
-
Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease
NCT00504803 ·Status: COMPLETED ·Phase: PHASE2
-
Pathological Myeloid Activation After Sepsis and Trauma
NCT05616130 ·Status: RECRUITING
-
Transplant T CD4+ CCR7+ In Hematopoietic Stem Cells Allograft
NCT03280290 ·Status: COMPLETED ·Phase: NA
-
Donor-Derived Humoral Immunity, Hematopoietic Stem Cell Transplantation, TAR
NCT01611298 ·Status: COMPLETED ·Phase: NA
-
National Marrow Donor Program Long-Term Donor Follow-Up
NCT01362179 ·Status: COMPLETED
-
The Efficacy and Safety of Desensitation Regimen for Patients With High Titers of Anti-HLA Antibodies Prior to Allo-HSCT
NCT06362967 ·Status: RECRUITING ·Phase: PHASE2
-
Cell Selection for Bone Marrow Transplants to Prevent Graft-Versus-Host-Disease
NCT00001872 ·Status: COMPLETED
-
Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood
NCT00143884 ·Status: TERMINATED ·Phase: PHASE2
-
Unmodified Versus Leuko-Reduced Allogeneic Red Blood Cells Transfusion in Cancer Patients
NCT00180869 ·Status: COMPLETED ·Phase: PHASE3
-
Immune Reconstitution in Stem Cell Transplant Recipients
NCT02129543 ·Status: RECRUITING
-
A Open Label, Post Marketing Surveillance Study Following Transfusion of INTERCEPT Platelet Components
NCT02549222 ·Status: COMPLETED
-
A Comparison of Dendritic Cell Content and T-Cell Phenotype Between Granulocyte Colony-Stimulating Factor (G-CSF) or G-CSF + Granulocyte Macrophage (GM)-CSF
NCT00208949 ·Status: TERMINATED ·Phase: PHASE2
-
Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation
NCT00002673 ·Status: COMPLETED ·Phase: PHASE2
-
Longitudinal Gene Expression Profiling in Adults After Traumatic Injury
NCT02656459 ·Status: COMPLETED
-
Reiki Effects on Bone Marrow Transplant Patients
NCT05694910 ·Status: UNKNOWN ·Phase: NA
-
Dendritic Cells in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation
NCT00450268 ·Status: UNKNOWN
-
Transfusion in Lower Risk MDS Patients: Predictors of Adequacy of Transfusion and Quality of Life in Lower Risk MDS
NCT06614595 ·Status: RECRUITING
-
Effect of Indication Based Blood Product Transfusion in Patients Undergoing Major Oncological Surgery
NCT05607940 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2/PHASE3
-
T-Cell Depletion in Unrelated Donor Marrow Transplantation
NCT00000591 ·Status: COMPLETED ·Phase: PHASE3
-
Ex Vivo Expanded NK Cells Infusion Decrease Relapse Post Hematopoietic Stem Cell Transplantation
NCT05250362 ·Status: RECRUITING ·Phase: PHASE1/PHASE2